The researcher analyzed two emotion regulation strategies in a group of adults attending psychodrama psychotherapeutic group at an outpatient psychiatric clinic. The subjects, nine men and 15 women ...between the ages of 19 and 63 (with 14 subjects in young and 10 in middle adulthood) self-assessed their use of reappraisal and suppression using the Emotion Regulation Questionnaire at the beginning of their treatment and at its end. They use reappraisal rarely to sometimes, regardless of their age, gender, and diagnosis. In the first assessment, the participants in middle adulthood and men reported using suppression more than young adults and women. During treatment, middle-aged adults and men succeeded to decrease their use of suppression significantly more than the young adults and women.
In the present article of the Zeitschrift für Psychodrama und Soziometrie, the expectations (self-assessed at the beginning of the treatment) and perception (self-assessed upon the conclusion of the ...treatment) of the psychotherapy process and outcome, psychotherapeutic factors and psychodrama specificities are presented and analysed in a psychodrama group for adult participants held in an outpatient psychiatric clinic. There were 12 male and 31 female participants, aged from 19 to 63 years, diagnosed with anxiety, depression, and borderline personality disorder or committed into the hospital after their first psychotic episode. Questionnaires were applied at the beginning of the treatment and at the end. Results showed that the participants’ expectations regarding the psychotherapy process and outcomes were quite high at the beginning of the treatment and rose significantly at the end. The same was true of the participants’ expectations and perception of the specificities of psychodrama—demonstrating the participants’ positive inclination towards this specific psychotherapeutic way of conducting psychodrama. Even though there were no age or gender differences, there were, differences between participants’ different diagnoses; there were significant differences in the expectations of both psychotherapy outcome and factors before treatment and perceptions of them after treatment.
The evidence of increased cardiovascular disease (CVD) risk in posttraumatic stress disorder (PTSD) is accumulating. The present study aimed to determine whether chronic, combat-related PTSD is ...associated with serum lipid and homocysteine concentrations that could indicate higher CVD risk.
The authors tested 66 war veterans with PTSD, 33 war veterans without PTSD, and 42 healthy volunteers for serum concentrations of homocysteine, total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and triglycerides. All the subjects were men and the analyses were adjusted for age, body mass index and smoking. Potential influences of depression, anxiety, and psychotic symptoms on the outcome measures were checked by introducing the scores from the Hamilton Depression Rating Scale (HAM-D-17), the Hamilton Anxiety Scale (HAMA), and the Positive and Negative Syndrome Scale (PANSS) into the overall statistical model.
No differences in total cholesterol, LDL-C, HDL-C and triglycerides were found between the groups. Non-smoking PTSD war veterans had higher homocysteine concentrations (mean
=
10.4 μmol/L, SD
=
1.7) when compared to non-smoking war veterans without PTSD (mean
=
8.2 μmol/L, SD
=
4.0,
P
=
0.014) and both smoking (mean
=
8.7 μmol/L, SD
=
2.3,
P
=
0.008) and non-smoking healthy volunteers (mean
=
8.8 μmol/L, SD
=
2.2,
P
=
0.021).
The results of our cross-sectional study are possibly confounded by many factors, especially behavioral and life-style related which are difficult to control comprehensively and might have influenced serum lipids and homocysteine concentration in a complex manner.
An increase in the homocysteine concentration observed in the non-smoking PTSD patients needs further investigation with a carefully designed prospective study to confirm associated, possibly enhanced CVD risk.
Cilj ovog rada je prikazati mentalno zdravlje osoba oboljelih od Alzheimerove bolesti opisivanjem neuropsihijatrijskih
simptoma koji se javljaju tijekom bolesti te putem sustavnog prikaza ...istraživanja prevalencije navedenih simptoma.
Neuropsihijatrijski simptomi Alzheimerove bolesti su simptomi koji uključuju promjene ličnosti, poremećaje
raspoloženja, motoričkih aktivnosti i brojne druge promjene koje osim samog oboljelog mogu opaziti i osobe u
okolini bolesnika (liječnici, njegovatelji i dr.). Također, simptomi negativno utječu ne samo na oboljele, već i na osobe
oko njih (obitelj, njegovatelji, sustav skrbi za oboljele, te cjelokupno društvo).
Rad prikazuje Alzheimerovu bolest općenito i njezine neuropsihijatrijske simptome njihovim definiranjem, opisom,
načinom tretmana, mjerenjem i grupiranjem. U radu je prikazana i prevalencija neuropsihijatrijskih simptoma, te
su nalazi dobiveni sustavnom analizom dostupnih istraživanja uspoređeni s nalazima ranijih istraživanja. Tako su
najčešći bili simptomi apatije, depresije i iritabilnosti, a najrjeđi simptomi euforije i halucinacije, što je bilo u skladu s
nalazima ranijih istraživanja (uz manja odstupanja, koja su također prikazana u radu). S obzirom na očekivani porast
starijih osoba u društvu te samim tim i oboljelih od raznih vrsta demencije (od kojih je Alzheimerova bolest najčešća),
očekivano je da će rasti interes kako za samu bolest, tako i za njezine simptome.
PDF
